Latest News

Billy Joel is canceling all of his shows for 2025 after being diagnosed with a brain disorder that can cause physical and cognitive impairment. NPH affects adults aged 65 and over, and best estimates put the number of people battling the condition at about 700,000. But Dr. Charles Matouk, a neurosurgeon and professor at the Yale School of Medicine, tells Rolling Stone that NPH is probably “much more common than we think. It’s just profoundly underdiagnosed in this country.”

A Yale-led study shows that the senses stimulate a region of the brain that controls consciousness—a finding that might inform treatment for disorders related to attention, arousal, and more.  

Researchers need to find solutions differently than in the past to break through with treatments for aggressive brain cancers.

An innovative new tool known as CellPyAbility was recently developed by James Elia, a doctoral candidate studying in the lab of Ranjit Bindra, MD, PhD.

A pair of research articles, based on multi-institution research exploring glioblastoma (GBM) ecosystems, reveal findings that include new patterns that could be signposts to help guide treatment choices for the aggressive brain cancer and its recurrences. Published May 9 in Nature Genetics, the findings are from many research institutions across the globe, including the Yale Cancer Center. Researchers sought to better understand the varied cell types that typify the hard-to-treat cancer based on tumor samples from both primary and recurring cancers in 59 patients.

Understanding the fast-moving advancements in radiation oncology in a conversation wtih Dr. James Hansen.

May in brain cancer awareness month – a time dedicated to raising awareness about the disease, symptoms and treatments.

A new Yale study offers new insight into how morphogens help regulate the development of stem cells into specialized brain cells.

Yale Cancer Center faculty and trainees joined 22,000 cancer researchers from around the world to share the latest advances in cancer science and medicine earlier this week in Chicago for the 116th American Association for Cancer Research (AACR) annual meeting. Dr. Patricia LoRusso, Amy and Joseph Perella Professor of Medicine at Yale Cancer Center and AACR President for 2024-25, shared her global view on cancer. “Cancer is a global disease—it spares no continent, no country. And each patient that gets the disease deserves treatment.”